Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common stock, $0.001 par value
-
Shares outstanding
-
78.8M
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
19.1M
-
Shares change
-
+8.31M
-
Total reported value, excl. options
-
$75.5M
-
Value change
-
+$32.9M
-
Put/Call ratio
-
2.55
-
Number of buys
-
55
-
Number of sells
-
-25
-
Price
-
$3.97
Significant Holders of CorMedix Inc. - Common stock, $0.001 par value (CRMD) as of Q2 2023
104 filings reported holding CRMD - CorMedix Inc. - Common stock, $0.001 par value as of Q2 2023.
CorMedix Inc. - Common stock, $0.001 par value (CRMD) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.1M shares
of 78.8M outstanding shares and own 24.19% of the company stock.
Largest 10 shareholders include NOMURA HOLDINGS INC (2.95M shares), BlackRock Inc. (2.72M shares), VANGUARD GROUP INC (2.55M shares), Elliott Investment Management L.P. (1.55M shares), MARSHALL WACE, LLP (1.44M shares), CVI Holdings, LLC (1.11M shares), Alyeska Investment Group, L.P. (1M shares), GEODE CAPITAL MANAGEMENT, LLC (851K shares), STATE STREET CORP (813K shares), and MILLENNIUM MANAGEMENT LLC (518K shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.